Consumer staple stocks are holiday laggards
Despite setting multi-year highs, we find overvalued stocks with charts like toppling blocks.

By Richard Suttmeier
In the days after Christmas all through the house we see evidence of consumer products. There are half full glasses of alcohol cheer, and empty bottles of dad's favorite beer. There are leftover cans of our favorite soft drink. The stockings were emptied of candy and stuff, from soaps to toothpaste to perhaps an ear muff.
When accessing the sector we find overvalued stocks with charts that look like toppling blocks. Merry Christmas and a Happy New Year!
The consumer staples sector is the second most overvalued among the 16 sectors covered at www.ValuEngine.com, overvalued by 15.4%. The alcoholic beverage industry is 12.1% overvalued with soft drinks 9.2% overvalued while cosmetics and toiletries are 8.0% undervalued.
In tracking the sector technically I look at the daily and weekly charts for the Consumer Staples Sector SPDR Fund (XLP).
The daily chart for XLP ($35.06) gapped below its 50-day simple moving average at $35.50 on Friday, but stayed above its 200-day SMA at $34.91 on Monday. The daily chart profile is negative, which is a technical warning that consumer staples stocks have lagged during the 2012 holiday shopping season.
The weekly chart profile (not shown) provides another warning for the sector given a close this week below the five-week modified moving average at $35.57. My annual value level is $32.87 with a weekly pivot at $35.41 and monthly risky level at $36.39.
- Also see: the retail bubble stocks are deflating

In prior posts covering the consumer staples sector on Aug. 6 I wrote, Book Profits in Overvalued Consumer Staples, and on Sept. 18 wrote, Continue to Book Profits in Consumer Staples. Today I profile two consumer staples stocks rated "strong buy" and seven that are rated "buy," giving investors and traders my latest buy-and-trade guidance.

OV/UN Valued: Stocks with a red number are undervalued by this percentage. Those with a black number are overvalued by that percentage according to ValuEngine.
VE Rating: A "1-engine" rating is a strong sell, a "2-engine" rating is a sell, a "3-engine" rating is a hold, a "4-engine" rating is a buy and a "5-engine" rating is a strong buy.
Last 12-Month Return (%): Stocks with a red number declined by that percentage over the last 12 months. Stocks with a black number increased by that percentage.
Forecast 1-Year Return: Stocks with a red number are projected to decline by that percentage over the next 12 months. Stocks with a black number in the table are projected to move higher by that percentage over the next 12 months.
Value Level: Price at which to enter a GTC limit order to buy on weakness. The letters mean; W-weekly, M-monthly, Q-quarterly, S-semiannual and A-annual.
Pivot: A level between a value level and risky level that should be a magnet during the time frame noted.
Risky Level: Price at which to enter a GTC limit order to sell on strength.
Ambev (ABV) ($41.96): Set a multi-year high at $44.63 on April 20. The stock is rated "strong buy," is 19.2% overvalued and has an elevated trailing 12 months price-to-earnings ratio of 27.2. The daily chart is neutral with the 50-day and 200-day SMAs at $41.06 and $39.56. The weekly chart shifts to negative with a close this week below the five-week MMA at $41.32. My monthly value level is $38.03 with a weekly pivot at $41.98 and semiannual risky level at $43.14.
Anheuser Busch (BUD) ($87.54): Set a multi-year high at $91.20 on Oct. 5. The stock is rated "strong buy," is 10.2% overvalued and has a slightly elevated trailing 12 months P/E of 18.9. The daily chart is negative with the 50-day and 200-day SMAs at $85.98 and $78.92. The weekly chart stays positive with a close this week above the five-week MMA at $86.78. My quarterly value level is $76.90 with a weekly pivot at $87.00 and monthly risky level at $89.28.
Colgate Palmolive (CL) ($105.05): Set a multi-year high at $110.97 on Oct. 17. The stock is rated "buy," is 6.7% overvalued and has a slightly elevated trailing 12 months P/E of 19.8. The daily chart is negative with the 50-day and 200-day SMAs at $106.54 and $103.07. The weekly chart stays negative with a close this week below the five-week MMA at $106.09. My semiannual value level is $101.69 with a weekly risky level at $108.33.
General Mills (GIS) ($41.00): Set a multi-year high at $41.88 on Dec. 19. The stock is rated "buy," is 0.4% overvalued and has a reasonable trailing 12 months P/E of 15.8. The daily chart is negative with the 50-day and 200-day SMAs at $40.35 and $39.24. The weekly chart shifts to negative with a close this week below the five-week MMA at $40.69. My quarterly value level is $40.34 with a weekly risky level at $41.33.
Kellogg (K) ($56.14): Set its 2012 high at $57.21 on Dec. 12. The stock is rated "buy," is 3.9% overvalued and has a reasonable trailing 12 months P/E of 16.5. The daily chart is neutral with the 50-day and 200-day SMAs at $54.42 and $51.56. The weekly chart is overbought with the five-week MMA at $55.19. My quarterly value level is $54.03 with a weekly risky level at $57.57.
Kimberly-Clark (KMB) ($83.79): Set a multi-year high at $88.25 on Aug. 3. The stock is rated "buy," is 3.9% overvalued and has a reasonable trailing 12 months P/E of 16.1. The daily chart is negative with the 50-day and 200-day SMAs at $85.11 and $81.95. The weekly chart remains negative with a close this week below the five-week MMA at $84.76. My annual value level is $80.29 with a quarterly pivot at $83.54 and weekly risky level at $86.94.
Coca-Cola (KO) ($36.73): Set a multi-year high at $40.67 on July 31. The stock is rated "buy," is 7.6% undervalued and has a slightly elevated trailing 12 months P/E of 18.5. The daily chart is negative with the 50-day and 200-day SMAs at $37.24 and $37.72. The weekly chart shifts to negative with a close this week below the five-week MMA at $37.29. My semiannual value level is $29.30 with a semiannual pivot at $36.63 and weekly risky level at $37.39.
Pepsico (PEP) ($69.43): Set a multi-year high at $73.66 on Aug. 27. The stock is rated "buy," is 4.6% overvalued and has a reasonable trailing 12 months P/E of 16.9. The daily chart is negative with the 50-day and 200-day SMAs at $69.59 and $69.18. The weekly chart shifts is neutral with a close this week below the five-week MMA at $69.79. My quarterly value level is $68.44 with weekly risky level at $70.20.
Procter & Gamble (PG) ($68.52): Set a multi-year high at $70.99 on Dec. 12. The stock is rated "buy," is 2.6% overvalued and has a reasonable trailing 12 months P/E of 17.5. The daily chart is negative with the 50-day and 200-day SMAs at $68.87 and $66.32. The weekly chart shifts is negative with a close this week below the five-week MMA at $68.95. My monthly value level is $65.49, with a weekly pivot at $68.36 and quarterly risky level at $70.38.
At the time of publication the author held no positions in any of the stocks mentioned.
More from TheStreet.com
MORE ON MSN MONEY
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
LATEST POSTS
Try as the bears might, they couldn't break U.S. stocks. But investors still face frothy prices and considerable headwinds.
FIDELITY VIEWPOINTS
- How to sell covered calls - Fidelity Investments
- Savvy year-end tax moves to consider now - Fidelity Investments
- Seven ways to prepare for tax changes
- Five reasons an annual review is crucial - Fidelity Investments
- Take a look at mid caps now - Fidelity Investments
- State of the sector: Health care - Fidelity Investments
VIDEO ON MSN MONEY
ABOUT
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
